BioCentury
ARTICLE | Clinical News

Baycol cerivastatin: Trial update

September 5, 2000 7:00 AM UTC

Baycol is marketed to raise HDL cholesterol and reduce other lipid levels in patients with hypercholesterolemia and mixed dyslipidemia. ...